Breakdown of Science Funding in 2021 Appropriations Request

Given the breadth and diversity of the microbial sciences field, there are multiple federal agencies and programs that influence the work of ASM and its members. The chart below, compiled by ASM’s Policy team, provides additional information on the funding levels across these agencies, from current levels, to the President’s FY 2021 budget request, to the most up-to-date FY 2021 Congressional proposals. You can explore how the FY 2021 request and proposed funding levels compare with the current, FY 2020 enacted funding levels. The chart provides a glimpse into both the White House’s and Congress’ priorities as they relate to the microbial sciences and infectious disease.
 
Note: In the wake of COVID-19, there have been supplemental funding bills enacted that have provided additional, emergency funding in the current fiscal year and to be used over multiple years. These funds primarily have been directed to the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID), the Centers for Disease Control and Prevention (CDC) and the Biomedical Advanced Research and Development Authority (BARDA). 
 
 

Department of Health and Human Services

 
AGENCY/PROGRAM FY20 ENACTED PRES. FY21 REQUEST House FY21
HHS: Public Health and Social Services Emergency Fund $2.737 billion $2.641 billion $2.8 billion
Biomedical Advanced Research and Development Authority (BARDA) $562 million $562 million $562 million
*see below for details on emergency provisions
 
AGENCY/PROGRAM FY20 ENACTED PRES. FY21 REQUEST House FY21
National Institutes of Health $41.7 billion $38.6 billion $42 billion
National Institute of Allergy and Infectious Diseases (NIAID) $5.885 billion $5.445 billion $6.013 billion
*see below for details on emergency provisions
 
AGENCY/PROGRAM FY20 ENACTED PRES. FY21 REQUEST House FY21
Food and Drug Administration (budget authority) $3.160 billion $3.206 billion $3.212 billion 
 
AGENCY/PROGRAM FY20 ENACTED PRES. FY21 REQUEST House FY21
Centers for Disease Control and Prevention $7.7 billion $7.0 billion $7.98 billion
Emerging and Zoonotic Infectious Disease $635.77 million $550.46 million $645.9 million
Immunization and Respiratory Disease $790 million $830 million  $840 million
HIV/AIDS, Viral Hepatitis, STI and TB Prevention $1.273 billion  $1.552 billion  $1.3 billion
Global Health $570.84 million $532.22 million $572.8 million
Public Health Preparedness $827.2 million $802 million $852 million
* see below for details on emergency provisions
 

Department of Agriculture

AGENCY/PROGRAM FY20 ENACTED PRES. FY21 REQUEST House FY21
Agriculture and Food Research Initiative $425 million $600 million $435 million
National Institute of Food and Agriculture $962,864 $1.596 billion $997 million
 

Department of Energy

AGENCY/PROGRAM FY20 ENACTED PRES. FY21 REQUEST House FY21
Department of Energy Office of Science $7.000 billion $5.838 billion $13.2 billion
*see below for details on emergency provisions

Other Relevant Agencies and Programs

AGENCY/PROGRAM FY20 ENACTED PRES. FY21 REQUEST House FY21
National Science Foundation $8.278 billion $7.741 billion $8.55 billion
 
AGENCY/PROGRAM FY20 ENACTED PRES. FY21 REQUEST House FY21
National Oceanic and Atmospheric Administration (NOAA) Research Office $590 million $353 million $584 million
U.S. Geological Survey (USGS) $1.271 billion $971 million $1.293 billion
Environmental Protection Agency (EPA): Science and Technology $716 million $644 million $745 million
National Aeronautics and Space Administration (NASA) Science Directorate $7.069 billion $6.307 billion $7.09 billion


Information about Emergency Provisions


 Biomedical Advanced Research and Development Authority (BARDA)   the bill includes $4.5 billion in emergency supplemental appropriations for BARDA to support advanced research and development and advanced manufacturing of vaccines and therapeutics to improve the nation’s preparedness for public health emergencies.


Back to top

National Institutes of Health (NIH)  $47 billion for NIH total
 
$42 billion of this is “regular” FY 2021 appropriations (a $500 million increase over current levels)
 
The remaining $5 billion is designated as “emergency” spending and would be allocated across all institutes, not just NIAID, to provide relief from losses associated with COVID-19 related laboratory closures.
 
NIAID: $6.013 billion  
 
  • The bill proposes targeted investments in several high-priority areas, including:
    • $240 million for Universal Flu Vaccine Research, an increase of $40 million above the FY 2020 enacted level;
    • $3.1 billion for HIV/AIDS research, an increase of $37 million above the FY 2020 enacted level

Back to top
 
Centers for Disease Control and Prevention (CDC) – The bill includes a total of $17 billion for CDC.
 
$7.98 billion is "regular" appropriations (an increase of $232 million above the FY 2020 enacted level)
 
The bill includes $9 billion in emergency supplemental appropriations for CDC targeted to preparedness and public health emergencies.
 
  • The bill proposes investments in the following as part of the FY 2021 “regular” appropriations:
    • $645.9 million for the National Center for Emerging and Zoonotic Infectious Diseases
    • $840 million for Immunization and Respiratory Diseases.
    • $572.8 million or Global Health.
    • $363 million, an increase of $10 million above the FY 2020 enacted level, for epidemiologic and laboratory support at State and eligible public health agencies.
    • $852 million for Public Health Preparedness and Response
    • $1.3 billion for HIV/AIDS, Viral Hepatitis, STI and TB Prevention
Included in the $9 billion in emergency supplemental funding are the following proposed levels:
  • $4 billion for enhanced public health prevention efforts, including an influenza vaccination campaign.
  • $2 billion for Public Health Emergency Preparedness cooperative agreements to increase State and local public health emergency response capabilities.
  • $1 billion to improve capabilities at State and local public health laboratories.
  • $1 billion to strengthen global public health preparedness and response capacity.
  • $400 million for the multi-year effort to modernize public health data surveillance and analytics.
  • $400 million for the Infectious Diseases Rapid Response Reserve Fund.
  • $200 million for public health workforce development.

Back to top

Department of Energy Office of Science  $7.05 billion, an increase of $50 million above the FY 2020 level, is included for FY 2021.

The remaining $6.25 billion is marked as  emergency supplemental appropriations for national laboratories, scientific user facilities, and universities to accelerate ongoing construction projects across the country


Back to top

 

Author: ASM Advocacy

ASM Advocacy
ASM Advocacy is making it easy and providing opportunities for members to advocate for evidence-based scientific policy.